The analysis of mRNA expression showed that AEBP1 was upregulated in the AD patients, whereas AK5, COPG2IT1, CARTPT, and NPTX2 were downregulated in AD patients (Fig. 9A). Here, COPG2IT1 is linked to Alzheimer disease.